9,425
Total Claims
$1.4M
Drug Cost
1,339
Beneficiaries
$1,059
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-31%
Cost per patient vs peers
$1,059 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,054 claims · $201K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 591 | $609K |
| Sacubitril/Valsartan | 145 | $184K |
| Rivaroxaban | 140 | $131K |
| Evolocumab | 84 | $86K |
| Dronedarone Hcl | 50 | $57K |
| Empagliflozin | 36 | $52K |
| Ezetimibe | 716 | $29K |
| Dapagliflozin Propanediol | 26 | $26K |
| Vericiguat | 28 | $22K |
| Potassium Chloride | 544 | $21K |
| Ranolazine | 94 | $15K |
| Midodrine Hcl | 106 | $15K |
| Alirocumab | 14 | $11K |
| Ticagrelor | 13 | $11K |
| Isosorbide Mononitrate | 298 | $10K |
Prescribing Profile
63
Unique Drugs
$1.0M
Patient Profile
75
Avg Age
46%
Female
1.59
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data